Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study
Selina R. van den Oever(Princess Máxima Center), Eliana Charalambous(Health Level Seven International), Diana Walz, Maria Van Helvoirt(KU Leuven), G. Schreier(Austrian Institute of Technology), Ruth Ladenstein(St Anna Children's Hospital), Vanessa Düster, Helena J. H. van der Pal, Dorothea Niehoff(German Cancer Research Center), Zuzana Tomášiková, Gerald Gredinger, Giacomo Cavalca, Catherine Chronaki(Health Level Seven International), Anna‐Liesa Filbert(Johannes Gutenberg University Mainz), Giorgio Cangioli(Health Level Seven International), Adela Cañete(Universitat de València), Jelena Rascon(Vilnius University), Jessica Trollip(Princess Máxima Center), Friederike Erdmann(Johannes Gutenberg University Mainz), Riccardo Haupt(Istituto Giannina Gaslini), Tiago R. D. Costa(Associação de Assistência à Criança Deficiente), Marie Alfes, Edit Bárdi(Kepler Universitätsklinikum), Ismay A E de Beijer(Princess Máxima Center), Anja Laschkolnig(Gesundheit Österreich), Justas Trinkūnas, Claudia Spix(Johannes Gutenberg University Mainz), Monica Muraca(Istituto Giannina Gaslini), Thorsten Langer, Leontien C.M. Kremer(University Medical Center Utrecht), Kathrin Trunner(Gesundheit Österreich), Alexander Degelsegger(Gesundheit Österreich), Julia Balaguer(Hospital Universitari i Politècnic La Fe), Anne Uyttebroeck(Inserm), María Teresa Tormo(Instituto de Investigación Sanitaria La Fe), Desiree Grabow(Johannes Gutenberg University Mainz), Saskia M. F. Pluijm(Princess Máxima Center), Simone Lightwood, Francesca Bagnasco, Sara Oberti(Istituto Giannina Gaslini), Hannah Gsell, Brigitte Nicolas
Cited by 11
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|641
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Cardioprotective interventions for cancer patients receiving anthracyclines
|Cochrane Database of Systematic Reviews|2011|553